サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1781279

HPV関連疾患治療の世界市場

HPV Associated Disorders Treatment

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
HPV関連疾患治療の世界市場
出版日: 2025年08月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

HPV関連疾患治療の世界市場は2030年までに246億米ドルに達する見込み

2024年に199億米ドルと推定されるHPV関連疾患治療の世界市場は、2024～2030年の分析期間においてCAGR 3.6%で成長し、2030年には246億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである子宮頸部上皮内新形成は、CAGR 2.5%を記録し、分析期間終了時には59億米ドルに達すると予測されます。子宮頸がんセグメントの成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は54億米ドルと推定、中国はCAGR6.4％で成長予測

米国のHPV関連疾患治療市場は、2024年に54億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに49億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5％と2.7％と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界のHPV関連疾患治療市場- 主要動向と促進要因のまとめ

なぜHPV関連疾患の治療領域は子宮頸がん以外にも拡大しつつあるのか？

ヒトパピローマウイルス（HPV）治療市場は、子宮頸がんにとどまらない広範なHPV関連疾患の認知拡大に伴い、急速な進化を遂げています。子宮頸がんは依然としてHPVに関連する疾患として最も認知され、調査されていますが、肛門がん、外陰がん、膣がん、陰茎がん、口腔咽頭がんなど、他の悪性腫瘍の発生率も上昇しており、治療介入の幅が広がっています。このことは、HPVに関連した頭頸部がんが、特に若年成人の間で顕著なペースで増加している男女両方の集団において特に関連しています。HPV DNA検査や分子バイオマーカーを含むスクリーニングや診断能力の拡大は、早期発見と臨床介入に寄与し、HPV陽性患者に合わせた標的治療薬、免疫療法、外科的管理ソリューションの需要を加速しています。

これと並行して、性器疣贅や再発性呼吸器乳頭腫症（RRP）のような非腫瘍性HPV症状も、医学的関心が高まっています。これらの疾患は良性ではあるが、患者の身体的、心理的、経済的負担が大きく、レーザー焼灼、凍結療法、免疫調節薬などの介入を繰り返す必要があることが多いです。そのため、治療の焦点は、病変の除去だけでなく、ウイルスクリアランスや再発予防にも取り組むアプローチへと移行しつつあります。このように、HPV関連疾患の多様で持続的な性質が認識されるにつれ、腫瘍医、皮膚科医、婦人科医、感染症専門医が治療の場を超えて参加する、より包括的で集学的な治療エコシステムが構築されつつあります。

免疫療法、ワクチン接種、プレシジョンメディシンの進歩は、治療法をどのように変えていくのか？

免疫療法は、HPV関連がんの治療において有望な治療法として台頭してきており、特に、従来の治療法では不十分なことが多い再発・転移がんの治療において有望です。チェックポイント阻害剤（PD-1/PD-L1阻害剤など）は、HPVに起因する頭頸部扁平上皮がん（HNSCC）や進行子宮頸がんにおいて臨床効果を示しています。これらの治療法は、ウイルスに感染した細胞を認識し排除するT細胞の活性を回復させることで効果を発揮します。さらに、既存のHPV感染症の治癒やHPV陽性新生物の治療を目的とした治療用ワクチンも臨床試験が進んでおり、E6およびE7オンコプロテインを標的とし、強力な免疫応答を刺激する候補がいくつかあります。これらの治験用ワクチンは、予防ワクチン接種の効果が得られない患者に対して、疾患修飾効果をもたらす可能性があります。

さらに、精密医療と分子腫瘍学は、HPV遺伝子型、ウイルス量、宿主の遺伝子マーカーに基づいて、より個別化された治療アプローチを可能にしつつあります。放射線療法や化学療法と組み合わせた標的療法は、全身毒性を最小限に抑えながら生存率を改善する可能性が検討されています。ロボット支援手術や高解像度の画像誘導放射線治療などの技術も、特に中咽頭のような解剖学的に複雑な部位におけるHPV関連腫瘍の局所制御を改善しています。同時に、性器疣贅のような非悪性疾患に対しては、イミキモド、シネカテキンなどの局所免疫調節薬や抗ウイルス療法が第一選択薬として使用され続けているが、より高い有効性と再発率の減少を目指して、より新しい薬剤が研究されています。このような免疫学的、分子生物学的、標的治療学的な技術革新の融合により、HPV関連疾患の病期や病態を問わず、HPV関連疾患の管理に利用できる臨床的な武器が拡大しつつあります。

HPV治療に対する市場需要に影響を与えている疫学的・公衆衛生的動向とは？

HPV関連疾患の世界の負担は、予防ワクチン接種率の持続的な格差と、複数の疾患経路におけるHPVの役割に対する認識の高まりの両方によって、増大しています。有効なHPVワクチンが利用可能であるにもかかわらず、多くの地域で成人集団の予防接種が不十分なままであり、慢性的なHPV感染や関連疾患の進行に罹患しやすい集団が多数残されています。特に、低・中所得国（LMICs）では、検診、診断、治療へのアクセスが依然として大きな障壁となっており、子宮頸がんによる死亡率の高さとHPVの未治療の一因となっています。このような格差は、国のがん対策プログラムに治療アクセスを組み込むだけでなく、スケーラブルで費用対効果の高い治療ソリューションの緊急の必要性を生み出しています。

同時に、世界の公衆衛生イニシアチブは、早期介入と治療のインフラを強化しています。公衆衛生上の問題として子宮頸がんを撲滅しようという世界保健機関（WHO）の呼びかけにより、HPVスクリーニング、コルポスコピーサービス、およびループ電気外科切除法（LEEP）や凍結療法などの前がん病変除去技術への投資が増加しています。高所得国では、男女ともにHPV検査のガイドラインが拡大され、HPVに関連する頭頸部がんのサーベイランスが強化されたことで、症例の特定と臨床への関与が高まっています。このような取り組みは、教育キャンペーンや医療システムの能力向上と相まって、診断・治療経路への患者の流入を増加させ、HPV治療市場における薬理学的、外科的、手技的介入に対する一貫した需要拡大に寄与しています。

治療分野と世界地域にわたるHPV関連疾患治療市場の成長の原動力は？

HPV関連疾患治療市場の成長は、HPV疾患の罹患率の上昇、満たされていない治療ニーズ、医薬品、手術、診断の各領域における継続的な技術革新によってもたらされます。がん領域では、HPV陽性の子宮頸がんや口腔咽頭がんの増加により、先進的な全身療法、放射線増感剤、免疫がん治療薬に対する需要が高まっています。がん治療におけるコンパニオン診断とゲノム・プロファイリングの利用拡大により、患者の層別化と治療効果がさらに向上しています。皮膚科と性の健康分野では、性器疣贅の再発率の高さが、特に性的に活発な若年層の間で、効果的な外用剤、切除装置、予防レジメンに対する需要を支えています。

地域別では、北米と欧州が、高い認知度、強固な診断体制、新規治療薬の早期導入により、依然として主要市場となっています。しかし、アジア太平洋とラテンアメリカは、HPV検診率の上昇、治療へのアクセスの拡大、女性の健康とがん治療のインフラへの投資の増加などを背景に、急成長を遂げています。官民パートナーシップの台頭、ワクチン接種と連動したサーベイランスプログラム、分子診断への幅広いアクセスが、地域別治療市場の浸透をさらに加速しています。HPVが広範な悪性腫瘍や慢性疾患に関与していることがますます認識されるにつれ、包括的で学際的な治療ソリューションに対する需要が拡大し、HPV関連疾患治療市場は、世界のヘルスケア展望の中で、影響力が大きく、イノベーション主導のセグメントとして確固たる地位を築くことが予想されます。

セグメント

疾患タイプ（子宮頸部上皮内新生物、子宮頸がん、肛門上皮内新生物、肛門がん、性器いぼ、その他の疾患タイプ）、エンドユーザー（病院、外来手術センター、専門クリニック、その他のエンドユーザー）

調査対象企業の例

  • Abbott Molecular, Inc.
  • Antiva Biosciences
  • Biocon Ltd.
  • Bristol-Myers Squibb Company
  • Fujirebio Europe NV
  • GlaxoSmithKline plc.
  • Hologic, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Kite Pharma, Inc.
  • Merck & Co., Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31461

Global HPV Associated Disorders Treatment Market to Reach US$24.6 Billion by 2030

The global market for HPV Associated Disorders Treatment estimated at US$19.9 Billion in the year 2024, is expected to reach US$24.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Cervical intraepithelial neoplasia, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Cervical cancer segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 6.4% CAGR

The HPV Associated Disorders Treatment market in the U.S. is estimated at US$5.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global HPV Associated Disorders Treatment Market - Key Trends & Drivers Summarized

Why Is the Treatment Landscape for HPV-Associated Disorders Expanding Beyond Cervical Cancer?

The human papillomavirus (HPV) treatment market is undergoing rapid evolution as awareness expands around the wide spectrum of HPV-associated disorders that go well beyond cervical cancer. While cervical cancer remains the most recognized and researched HPV-linked condition, rising incidence of other malignancies-including anal, vulvar, vaginal, penile, and oropharyngeal cancers-is broadening the scope of therapeutic interventions. This is particularly relevant in both male and female populations where HPV-related head and neck cancers are increasing at a notable pace, especially among younger adults. The expansion of screening and diagnostic capabilities, including HPV DNA testing and molecular biomarkers, is contributing to earlier detection and clinical intervention, accelerating demand for targeted therapeutics, immunotherapies, and surgical management solutions tailored to HPV-positive patients.

In parallel, non-oncological HPV manifestations-such as genital warts and recurrent respiratory papillomatosis (RRP)-are also receiving increased medical attention. While benign, these conditions impose significant physical, psychological, and economic burdens on patients, often requiring repeated interventions such as laser ablation, cryotherapy, or immunomodulatory drugs. As such, the therapeutic focus is shifting toward approaches that address not only the elimination of lesions but also viral clearance and recurrence prevention. This growing recognition of the diverse and persistent nature of HPV-associated disorders is prompting a more comprehensive and multidisciplinary treatment ecosystem involving oncologists, dermatologists, gynecologists, and infectious disease specialists across care settings.

How Are Advances in Immunotherapy, Vaccination, and Precision Medicine Transforming Treatment Modalities?

Immunotherapy is emerging as a promising modality in the treatment of HPV-associated cancers, particularly in recurrent and metastatic settings where conventional therapies often fall short. Checkpoint inhibitors-such as PD-1/PD-L1 inhibitors-have demonstrated clinical efficacy in HPV-driven head and neck squamous cell carcinoma (HNSCC), as well as in advanced cervical cancer. These therapies work by restoring T-cell activity to recognize and eliminate virally transformed cells. Additionally, therapeutic vaccines aimed at clearing existing HPV infections or treating HPV-positive neoplasias are progressing through clinical trials, with several candidates targeting E6 and E7 oncoproteins to stimulate robust immune responses. These investigational vaccines offer potential disease-modifying benefits for patients who do not benefit from prophylactic vaccination.

Moreover, precision medicine and molecular oncology are enabling more personalized treatment approaches based on HPV genotype, viral load, and host genetic markers. Targeted therapies-combined with radiotherapy or chemotherapy-are being explored for their ability to improve survival while minimizing systemic toxicity. Techniques such as robotic-assisted surgery and high-resolution image-guided radiation therapy are also improving local control of HPV-related tumors, particularly in anatomically complex regions like the oropharynx. Concurrently, for non-malignant conditions such as genital warts, topical immunomodulators like imiquimod, sinecatechins, and antiviral therapies continue to serve as first-line options, with newer agents being explored for enhanced efficacy and reduced recurrence rates. This convergence of immunological, molecular, and targeted therapeutic innovation is expanding the clinical armamentarium available for managing HPV-associated disorders across disease stages and manifestations.

What Epidemiological and Public Health Trends Are Influencing Market Demand for HPV Treatments?

The global burden of HPV-associated disorders is escalating, driven by both persistent gaps in prophylactic vaccine coverage and growing awareness of HPV’s role in multiple disease pathways. Despite the availability of effective HPV vaccines, adult populations remain under-immunized in many regions, leaving a large pool of individuals susceptible to chronic HPV infections and related disease progression. In particular, low- and middle-income countries (LMICs) continue to face significant barriers to screening, diagnosis, and treatment access, contributing to high cervical cancer mortality and untreated HPV conditions. These disparities are creating an urgent need for scalable, cost-effective therapeutic solutions, as well as integration of treatment access into national cancer control programs.

Simultaneously, global public health initiatives are strengthening early intervention and treatment infrastructure. The World Health Organization's call to eliminate cervical cancer as a public health problem has led to increased investment in HPV screening, colposcopy services, and access to precancerous lesion removal techniques such as loop electrosurgical excision procedure (LEEP) and cryotherapy. In high-income countries, expanding guidelines for HPV testing in both men and women, along with enhanced surveillance of HPV-linked head and neck cancers, are driving higher case identification and clinical engagement. These efforts, combined with educational campaigns and health system capacity-building, are increasing patient throughput into diagnostic and treatment pathways, thereby contributing to consistent growth in demand for pharmacological, surgical, and procedural interventions in the HPV treatment market.

What Is Driving the Growth of the HPV Associated Disorders Treatment Market Across Therapeutic Areas and Global Regions?

The growth in the HPV associated disorders treatment market is driven by rising HPV disease incidence, unmet therapeutic needs, and continued innovation across pharmaceutical, procedural, and diagnostic domains. In oncology, increasing prevalence of HPV-positive cervical and oropharyngeal cancers is generating demand for advanced systemic therapies, radiosensitizers, and immuno-oncology agents. The expanding use of companion diagnostics and genomic profiling in cancer care is further enhancing patient stratification and treatment efficacy. In dermatology and sexual health, the high recurrence rate of anogenital warts is sustaining demand for effective topical agents, ablative devices, and preventive regimens, especially among younger, sexually active populations.

Regionally, North America and Europe remain leading markets due to high awareness, robust diagnostic frameworks, and early adoption of novel therapeutics. However, Asia-Pacific and Latin America are experiencing the fastest growth, driven by rising HPV screening rates, expanding access to treatment, and increasing investments in women’s health and cancer care infrastructure. The rise of public-private partnerships, vaccination-linked surveillance programs, and broader access to molecular diagnostics is further accelerating regional treatment market penetration. As HPV is increasingly recognized for its role in a broad array of malignancies and chronic conditions, the demand for comprehensive, multi-disciplinary treatment solutions is expected to grow-solidifying the HPV-associated disorders treatment market as a high-impact, innovation-driven segment within the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the HPV Associated Disorders Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Type (Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts, Other disease types); End-Use (Hospitals, Ambulatory Surgery Centers, Specialty clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Molecular, Inc.
  • Antiva Biosciences
  • Biocon Ltd.
  • Bristol-Myers Squibb Company
  • Fujirebio Europe NV
  • GlaxoSmithKline plc.
  • Hologic, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Kite Pharma, Inc.
  • Merck & Co., Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • HPV Associated Disorders Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of HPV Infections Drives Demand for Targeted Therapies
    • Increasing HPV Vaccination Awareness Expands Preventive and Early Intervention Markets
    • Technological Advancements in Molecular Diagnostics Accelerate HPV Screening Uptake
    • Pipeline Development for Immunotherapies and Targeted Drugs Strengthens Market Outlook
    • Inclusion of HPV Testing in Routine Women's Health Exams Increases Detection Rates
    • Expansion of Clinical Guidelines for HPV Management Propels Adoption of Drug Therapies
    • Growth in Cervical and Oropharyngeal Cancer Cases Fuels Need for Advanced Therapeutics
    • Strategic Collaborations Among Biopharma Companies Enhance R&D and Trial Success
    • Reimbursement Expansion in Developed Markets Increases Treatment Accessibility
    • Integration of Telehealth in Sexual Health Services Improves Diagnosis and Care Continuity
    • Regulatory Fast-Track Programs Encourage Market Entry for New HPV Therapies
    • Efforts Toward Male Inclusion in HPV Treatment Protocols Expand Patient Base
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World HPV Associated Disorders Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for HPV Associated Disorders Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for HPV Associated Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cervical intraepithelial neoplasia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cervical intraepithelial neoplasia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cervical intraepithelial neoplasia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cervical cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cervical cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cervical cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Anal intraepithelial neoplasia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Anal intraepithelial neoplasia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Anal intraepithelial neoplasia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Anal cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Anal cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Anal cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Genital warts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Genital warts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Genital warts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other disease types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other disease types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other disease types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Specialty clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Specialty clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Specialty clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • JAPAN
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • CHINA
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • EUROPE
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for HPV Associated Disorders Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for HPV Associated Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • FRANCE
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • GERMANY
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for HPV Associated Disorders Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for HPV Associated Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • INDIA
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for HPV Associated Disorders Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for HPV Associated Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for HPV Associated Disorders Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for HPV Associated Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030
  • AFRICA
    • HPV Associated Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for HPV Associated Disorders Treatment by Disease Type - Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for HPV Associated Disorders Treatment by Disease Type - Percentage Breakdown of Value Sales for Cervical intraepithelial neoplasia, Cervical cancer, Anal intraepithelial neoplasia, Anal cancer, Genital warts and Other disease types for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for HPV Associated Disorders Treatment by End-Use - Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for HPV Associated Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals, Ambulatory Surgery Centers and Specialty clinics for the Years 2015, 2025 & 2030

IV. COMPETITION